Efficacy of Different Low Level Laser Therapy Sessions

NCT ID: NCT06327204

Last Updated: 2024-03-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

90 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-03-01

Study Completion Date

2023-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Myofascial pain dysfunction syndrome is one of the common causes of non-odontogenic pain in the head and neck region. It accounts for 40-60% of the adult population. Different treatment modalities had been reported to release the trigger point within the muscles of mastication in order to reduce pain and allow recovery of the function.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Low-level laser therapy has been a research focus in past few years as it provides effective and conservative treatment modality with minimal patient discomfort. LLLT promotes the release of endogenous opioids, enhance tissue repair and cellular respiration, increase vasodilatation and pain relief Recent systematic review and meta-analysis had reported that the available evidence didn't allow clinicians to draw firm conclusions on effective dosage. This study aimed to investigate the effect of different LLLT sessions' number on pain, maximum mouth opening and quality of life in patients with masseter muscle trigger points.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Myofascial Pain Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group I

patient received one session / week

Group Type ACTIVE_COMPARATOR

940-nm diode laser / one session

Intervention Type DEVICE

laser therapy using a 940-nm diode laser / one session per week

group II

patient received two session / week

Group Type ACTIVE_COMPARATOR

940-nm diode laser / two session

Intervention Type DEVICE

laser therapy using a 940-nm diode laser / two session per week

Group III

Patient received three session / week

Group Type ACTIVE_COMPARATOR

940-nm diode laser/ three session

Intervention Type DEVICE

laser therapy using a 940-nm diode laser / three session per week

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

940-nm diode laser / one session

laser therapy using a 940-nm diode laser / one session per week

Intervention Type DEVICE

940-nm diode laser / two session

laser therapy using a 940-nm diode laser / two session per week

Intervention Type DEVICE

940-nm diode laser/ three session

laser therapy using a 940-nm diode laser / three session per week

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. definite diagnosis of myofascial pain based on the DC/TMD criteria with a referral
2. presence of one or more trigger points in the masseter muscle
3. no history of any invasive procedures of the related masseter muscle.

Exclusion Criteria

1. any painful conditions affecting the orofacial region
2. any systemic diseases that could masticatory function (e.g., rheumatoid arthritis and epilepsy)
3. pregnancy and lactation.
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

October 6 University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Amany Ahmed AlAraby

lecturer of Oral Medicine

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

amany Ahmed, PhD

Role: PRINCIPAL_INVESTIGATOR

faculty of dentistry, October 6 University, Egypt

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Faculty of Dentistry, October 6 University

Cairo, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

References

Explore related publications, articles, or registry entries linked to this study.

Ahrari F, Madani AS, Ghafouri ZS, Tuner J. The efficacy of low-level laser therapy for the treatment of myogenous temporomandibular joint disorder. Lasers Med Sci. 2014 Mar;29(2):551-7. doi: 10.1007/s10103-012-1253-6. Epub 2013 Jan 15.

Reference Type BACKGROUND
PMID: 23318917 (View on PubMed)

Maia ML, Bonjardim LR, Quintans Jde S, Ribeiro MA, Maia LG, Conti PC. Effect of low-level laser therapy on pain levels in patients with temporomandibular disorders: a systematic review. J Appl Oral Sci. 2012 Nov-Dec;20(6):594-602. doi: 10.1590/s1678-77572012000600002.

Reference Type BACKGROUND
PMID: 23329239 (View on PubMed)

Mahmoud NR, Shehab WI, AlAraby AA, Habaka YF. Efficacy of different low-level laser therapy sessions in the management of masseter muscle trigger points. BMC Oral Health. 2024 Sep 26;24(1):1125. doi: 10.1186/s12903-024-04780-y.

Reference Type DERIVED
PMID: 39327563 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Low Level laser 24

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Magnesium Sulfate and Trigger Points
NCT06975813 NOT_YET_RECRUITING PHASE2